NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.905
-0.015 (-0.78%)
At close: Sep 30, 2026, 4:00 PM EDT
1.910
+0.005 (0.26%)
After-hours: Sep 30, 2026, 4:10 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $204.83 million as of September 30, 2026. Its market cap has increased by 18.87% in one year.
Market Cap
204.83M
Enterprise Value
143.72M
1-Year Change
18.87%
Ranking
Category
Stock Price
$1.91
ChartMarket Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $204.83M, an increase of 447.24%. That is a compound annual growth rate of 25.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 204.83M | -54.05% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 227.22M |
| Entrada Therapeutics | 226.44M |
| Yarrow Bioscience | 226.42M |
| Keros Therapeutics | 225.44M |
| Protalix BioTherapeutics | 223.59M |
| Adagene | 220.90M |
| Whitehawk Therapeutics | 217.20M |
| Alector | 212.15M |